Pediatrics 2 experience, Neuropediatrics and neurometabolic diseases unit on phenylcetonuria: About 36 patients

F. ETIENE IRINEU 1, *, H. LACHRAF 1, H. RHOUDA 1, G. ZOUIRI 1, S. MOUSSAOUI 1, H. LAJJI 1, H. TALBAOUI 2, S. DAHRI 2, L. CHABRAOUI 2 and Y. KRIOUILE 1

1 Paediatric Neurology and Neurometabolic Disease Unit, Paediatric II Department, Faculty of Medicine and harmacy of Rabat, Rabat Children's Hospital, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco.
2 Department of Metabolic Biochemistry and Disease. CHU Ibn Sina, Rabat, Morocco.
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 22(01), 201–205
Article DOI: 10.30574/wjarr.2024.22.1.1023
 
Publication history: 
Received on 11 February 2024; revised on 01 April 2024; accepted on 03 April 2024
 
Abstract: 
Phenylketonuria (PKU) is a hereditary metabolic disease of phenylalanine metabolism, linked to a deficiency of phenylalanine hydroxylase or its cofactor, an enzyme allowing the transformation of phenylalanine into tyrosine, resulting in an increase in blood and brain concentration. of PHA, comprising an intellectual disability with cognitive and behavioral disorders if it is not treated. We report 36 cases of phenylketonuria followed in the pediatric department 2, born to consanguineous parents in 58.4% of cases and non-consanguineous in 41.6%, the male sex represents the majority with 22 cases and female with 14 cases, The age of diagnosis minimum 3 days of life and maximum 16 years and the current age of patients minimum 4 years and maximum 37 years with comorbidities like epilepsy, motor disorders, behavioral disorders, Autism Spectrum Disorder and mental retardation and about 70% have a regular monitoring. Through this series we will support the epidemiological, clinical, paraclinical and therapeutic particularities of patients with phenylketonuria. Early diagnosis of the disease makes it possible to initiate treatment early, which is mainly based on a diet low in phenylalanine for life in order to improve the progressive prognosis and avoid irreversible after-effects.
 
Keywords: 
Phenylketonuria; Phenylalanine; Phenylalanine Hydroxylase; Tetrahydrobiopterin
 
Full text article in PDF: 
Share this